Pfizer Fights Whistleblower Retaliation Suit In 2nd Circ.

Law360, New York (November 10, 2010, 6:14 PM EST) -- A former Pharmacia Inc. executive's retaliation suit against Pfizer Inc. alleging the drugmaker fired him for bringing a qui tam complaint is viable only if statements he made to Pfizer executives before the close of the companies' merger constituted notice of a whistleblower action, a federal appeals court was told Wednesday.

Ex-Pharmacia vice president Peter Rost’s statements — which allegedly alluded to his forthcoming qui tam suit over marketing of the drug Genotropin — were made to Pfizer executives before its merger with Pharmacia was finalized...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.